Given the urgent need for alternative strategies to block metastasis progression, we demonstrate that blocking HER2-mediated secondary metastasis improves clinical outcome and establish HER2 as a biomarker for bone metastasis in patients with initial HR+/HER2- breast cancer, which represents â¼70% of all cases.
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer.
阅读：9
作者：Alam Rahat, Reva Anna, Edwards David G, Lege Bree M, Munoz-Arcos Laura S, Reduzzi Carolina, Singh Swarnima, Hao Xiaoxin, Wu Yi-Hsuan, Tian Zeru, Natalee Laura M, Damle Gargi, Demircioglu Deniz, Wang Yixian, Wu Ling, Molteni Elisabetta, Hasson Dan, Lim Bora, Gugala Zbigniew, Chipuk Jerry E, Lang Julie E, Sparano Joseph A, Cheng Chonghui, Cristofanilli Massimo, Xiao Han, Zhang Xiang H-F, Bado Igor L
| 期刊： | Cancer Discovery | 影响因子： | 33.300 |
| 时间： | 2025 | 起止号： | 2025 Apr 2; 15(4):818-837 |
| doi： | 10.1158/2159-8290.CD-23-0543 | ||
特别声明
1、本文转载旨在传播信息，不代表本网站观点，亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用，必须保留本网站注明的“来源”，并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载，或需洽谈转载稿费等事宜，请及时与本网站联系。
4、此外，如需投稿，也可通过邮箱info@biocloudy.com与我们取得联系。